| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 268 |
| 1 | TOCILIZUMAB | 268 |
| 2 | ABATACEPT | 267 |
| 3 | ETANERCEPT | 267 |
| 4 | SULFASALAZINE | 266 |
| 5 | ADALIMUMAB | 265 |
| 6 | INFLIXIMAB | 265 |
| 7 | ANAKINRA | 264 |
| 8 | METHOTREXATE | 252 |
| 9 | PREDNISONE | 252 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VACCINIA IMMUNE GLOBULIN (HUMAN) | 1 | 0.1667 |
| 1 | ANAKINRA | 264 | 0.0306 |
| 2 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0286 |
| 3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 97 | 0.0144 |
| 4 | TRIAMCINOLONE ACETONIDE | 97 | 0.0059 |
| 5 | SULFASALAZINE | 266 | 0.0058 |
| 6 | TOCILIZUMAB | 268 | 0.0048 |
| 7 | ABATACEPT | 267 | 0.0035 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 142 | 0.0025 |
| 9 | NAPROXEN SODIUM | 204 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 280 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 268 |
| 2 | Aminosalicylate [EPC] | 267 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 267 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 264 |
| 5 | Corticosteroid [EPC] | 262 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 252 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 196 |
| 8 | Vitamin B12 [EPC] | 44 |
| 9 | Vitamin C [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 264 | 0.0306 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 268 | 0.0044 |
| 2 | Aminosalicylate [EPC] | 267 | 0.0036 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 267 | 0.0035 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0031 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 252 | 0.0009 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 280 | 0.0004 |
| 7 | Corticosteroid [EPC] | 262 | 0.0003 |
| 8 | Vitamin D [EPC] | 44 | 0.0003 |
| 9 | Vitamin B12 [EPC] | 44 | 0.0002 |